Methods: We retrospectively analyzed 162 NPC patients who were administered the PD-1 inhibitor combined with radiotherapy and chemotherapy at the Sun Yat-Sen University Cancer Center. The gene discussed is PDCD1; the disease is nasopharyngeal carcinoma.